Murine models of AD that are deficient in iNOS due to genetic ablation are protected from premature mortality, cerebral plaque formation, increased Aβ levels, protein tyrosine nitration, astrocytosis, and microgliosis (15). This evidence concerns the gene NOS2 and Alzheimer disease.